AZGP1 and cancer: AZGP1 has been suggested as a modifier of metabolic functions, insulin sensitivity, fat mass expansion, blood pressure regulation, cancer progression, inflammatory disease, vitiligo, neurological disease and cardiovascular (CV) disease4–9.